| NDC Code | 0078-0904-38 |
|---|
| Package Description | 1 BOTTLE in 1 CARTON (0078-0904-38) > 8 mL in 1 BOTTLE |
|---|
| Product NDC | 0078-0904 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Simbrinza |
|---|
| Non-Proprietary Name | Brinzolamide/brimonidine Tartrate |
|---|
| Dosage Form | SUSPENSION/ DROPS |
|---|
| Usage | OPHTHALMIC |
|---|
| Start Marketing Date | 20130501 |
|---|
| End Marketing Date | 20230228 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA204251 |
|---|
| Manufacturer | Novartis Pharmaceuticals Corporation |
|---|
| Substance Name | BRIMONIDINE TARTRATE; BRINZOLAMIDE |
|---|
| Strength | 2; 10 |
|---|
| Strength Unit | mg/mL; mg/mL |
|---|
| Pharmacy Classes | Adrenergic alpha-Agonists [MoA], Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], alpha-Adrenergic Agonist [EPC] |
|---|